| Disease | PRODUCTS CONTAINING GAMMA-BUTYROLACTONE (GBL) ARE CONVERTED BY THE BODY INTO GAMMA-HYDROXYBUTYRATE(GHB), HOWEVER GHB TOXICITY INCLUDE BRADYCARDIA, HYPOTHEIMIA, CENTRAL NERVOUS SYSTEM DEPRESSION AND UNCONTROLLED MOVEMENTS THE REPORT DESCRIBED 7
CASES OF GBL TOXICITY INVOLVING THE PRODUCT "REVIVARANT" WHICH CONTAINS 1.82 G OF GBL PER FLUID ONCE. THE PATIENTS DESCRIBED INVOLVED CONSUMING THE PRODUCT RANGING FROM 1 OZ-13OZ IN NEW MEXICO FROM OCT 3, 1998 THROUGH JANUARY 29,1999, THE POISON
CENTER IDENTIFIED 14 CASES OF ADVERSE ENENTS RESULTING FROM INGESTING BGL-CONTAINING PRODUCTS. WHILE 5 HAD INGESTED ETHANOL/DRUGS WITH IT. THE MOST COMMON SYMPTOMS AND SIGNS WERE NAUSEA/VOMITING, OBTUNDATION BRADYCARDIC PROLONGED UNCONSCIOUSNESS
SYNCOPE SEIZURES CONFUSION, COMBATIVENESS RESPIRATORY DEPRESSION, AMNESIRA, AND EUPHORIA. TEXAS POISON CONTROL-CENTERS REPORTED 20 ADVERSE EFFECTS BETWEEN THE SAME PERIOD OF TIME. |